Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies Experience from China
Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies Experience from China
Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies Experience from China
Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies Experience from China